IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc.

World Rank (Jan-05-2024)
5,323
Market Cap (Jan-05-2024)
2.231 Billion USD
World Rank (Jul-30-2023)
7,684
Market Cap (Jul-30-2023)
1.241 Billion USD
World Rank (Jan-07-2022)
11,494
Market Cap (Jan-07-2022)
0.692 Billion USD
World Rank (Jan-01-2021)
12,167
Market Cap (Jan-01-2021)
0.407 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
IDYA
Market Cap (Mar-08-2026)
2.92
Employee Count
103
Employee Count as of Date
As on 2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
51 Million USD
Annual Operating Income in USD
-63 Million USD
Annual Net Income in USD
-59 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
387 Million USD
Total Liabilities in USD
387 Million USD
Total Equity in USD
349 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Biotechnology
Company Website
IDEAYA BIOSCIENCES
Yahoo
Yahoo @ Nasdaq
Company Profile

IDEAYA is a synthetic lethality focused precision medicine oncology company developments and discovery of targeted therapeutics for patient populations selected using molecular diagnostics. The headquarters is in USA.

Facts About Company

IDEAYA Annual Total Revenue for year ending Dec-2022 was 50 million USD and and Net loss for year ending Dec-2022 was -58 million USD.

IDEAYA Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -50 million USD.

As on 2022, IDEAYA has 103 employees.

IPO Year
2019
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share